Clinical Trial Update: Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

View source ↗

Summary

Long-term follow-up data on the investigational TX200-TR101 therapy (STEADFAST Long Term) evaluating outcomes in kidney transplant rejection and end-stage renal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Rejection

Drugs mentioned

• TX200-TR101

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Kidney Transplant Rejection, End Stage Renal Disease | Status: ACTIVE_NOT_RECRUITING